Sanofi Japan Sales Dip 7.6% on Generic Erosion though Plavix Grew

Sanofi K.K. President Fabrice Baschiera Sanofi S.A.’s Japan pharmaceutical sales in 2014 sank 7.6% from the previous year to 293.5 billion yen on an NHI price basis as the growth of its best-selling antiplatelet agent Plavix (clopidogrel) failed to offset...read more